Literature DB >> 8356955

Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.

E R Burns1, S N Goldberg, B Wenz.   

Abstract

Single coagulation factor deficiencies predictably prolong the prothrombin time (PT) and activated partial thromboplastin time (APTT) at levels below 35% of normal activity. Acquired coagulopathies generally are characterized by multiple coagulation factor deficiencies. The effect was studied of such combined deficiencies on the PT/APTT using plasma from patients congenitally deficient in specific factors and pooled normal plasma. The PT begins to lengthen when individual factor levels fall below 25%. The APTT becomes prolonged when the levels of Factor V fall below 45%; the levels of Factors II and XI fall below 40%; and the levels of Factors I, V, VII, VIII, IX, and XII fall below 25% of normal. When plasma samples containing 50% activity of a single factor and 100% of all other factors were prepared by mixing the congenitally deficient plasma samples with the normal pool, the resulting mixtures had normal PT and APTT values. However, when two of these 50% factor-deficient plasmas were combined so that the mixture contained 75% activity of two coagulation factors and 100% of all other factors, the resulting PT and APTT were prolonged over the clotting times of either 50% factor-deficient plasma. Similar findings were obtained in patients with mild factor reductions caused by warfarin treatment. These data indicate that prolongations of the PT and APTT in disorders of coagulation affecting multiple factors represent less of a reduction in factor levels than is generally appreciated. This may explain the poor clinical correlation between abnormalities in these test results and clinical bleeding in acquired disorders of hemostasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8356955     DOI: 10.1093/ajcp/100.2.94

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy.

Authors:  B Vadher; D L Patterson; M Leaning
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  Clinical presentation and blood gas analysis of multiple trauma patients for prediction of standard coagulation parameters at emergency department arrival.

Authors:  P Hilbert-Carius; G O Hofmann; R Lefering; R Stuttmann; M F Struck
Journal:  Anaesthesist       Date:  2016-04-08       Impact factor: 1.041

3.  4 Plasma for Therapeutic Use.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

4.  Uses and abuses of fresh-frozen plasma for the prophylaxis of bleeding.

Authors:  M J Desborough; S J Stanworth
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

5.  Clinical relevance of isolated prolongation of the activated partial thromboplastin time in a cohort of adults undergoing surgical procedures.

Authors:  Giuseppe Tagariello; Paolo Radossi; Roberta Salviato; Milena Zardo; Lucia De Valentin; Marco Basso; Giancarlo Castaman
Journal:  Blood Transfus       Date:  2016-07-22       Impact factor: 3.443

Review 6.  [Management of bleeding disorders in intensive care medicine].

Authors:  S Petros
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-23       Impact factor: 0.840

7.  Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects.

Authors:  T T Knudsen; S Thorsen; S A Jensen; K Dalhoff; L E Schmidt; U Becker; F Bendtsen
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

8.  Plasma is ineffective in correcting mildly elevated PT-INR in critically ill children: a retrospective observational study.

Authors:  Esther Paula Soundar; Ronald Besandre; Sarah Kate Hartman; Jun Teruya; Shiu-Ki Rocky Hui
Journal:  J Intensive Care       Date:  2014-11-29

9.  Thromboelastometry versus standard coagulation tests versus restrictive protocol to guide blood transfusion prior to central venous catheterization in cirrhosis: study protocol for a randomized controlled trial.

Authors:  Leonardo Lima Rocha; Camila Menezes Souza Pessoa; Ary Serpa Neto; Rogerio Ruscitto do Prado; Eliezer Silva; Marcio Dias de Almeida; Thiago Domingos Correa
Journal:  Trials       Date:  2017-02-27       Impact factor: 2.279

10.  Effect of plasma component transfusion on conventional coagulation screening tests.

Authors:  Manish Raturi; Shamee Shastry; Mohandoss Murugesan; Poornima B Baliga; Kalyana Chakravarthy
Journal:  Asian J Transfus Sci       Date:  2018 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.